Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)

摘要

An overview of flow of each patient’s events. Abbreviations: end-of-treatment visit, late follow-up visit (42–49 days following the initiation of the treatment), test-of-cure visit (28–35 days following the initiation of treatment)